Ford's Jim Farley and Bill Ford say Ford is where it should be in terms of improved quality and profits. But investors still ...

Global Commercial Footprint -- Over 175 active sites are currently using ClearPoint technology, with expectations to surpass ...

NDA Submission Status -- D-PLEX100 rolling New Drug Application was initiated with the FDA on March 30, 2026, with CMC, nonclinical, and administrative modules submitted, and the clinical module ...